Nickells M, Hauhart R, Krych M, Subramanian V B, Geoghegan-Barek K, Marsh H C, Atkinson J P
Washington University School of Medicine, St Louis, MO 63110, USA.
Clin Exp Immunol. 1998 Apr;112(1):27-33. doi: 10.1046/j.1365-2249.1998.00549.x.
Complement receptor type one (CR1; CD35) binds and processes C3b and C4b opsonized immune complexes and regulates complement activation. We have characterized the epitopes of 13 previously reported and seven new MoAbs to human CR1. The MoAbs formed seven groups based on their reactivity with a panel of deletion forms of CR1. Seventeen of the MoAbs reacted with CR1 at more than one site, a consequence of its repetitive sequence. All five of the MoAbs recognizing epitopes in the nearly identical repeats 3, 10, and 17, as well as one MoAb which reacted with repeats 8 or 1/2 of 9 and 15 or 1/2 of 16, blocked cofactor activity for C3b. Knowledge of the repeats bearing the epitopes for these MoAbs should facilitate the further characterization of CR1.
一型补体受体(CR1;CD35)可结合并处理被C3b和C4b调理的免疫复合物,并调节补体激活。我们已对先前报道的13种及7种针对人CR1的新单克隆抗体的表位进行了表征。这些单克隆抗体根据其与一组CR1缺失形式的反应性形成了7组。其中17种单克隆抗体在多个位点与CR1发生反应,这是其重复序列的结果。所有5种识别几乎相同的重复序列3、10和17中表位的单克隆抗体,以及一种与重复序列8或9的1/2以及15或16的1/2发生反应的单克隆抗体,均阻断了C3b的辅因子活性。了解这些单克隆抗体表位所在的重复序列应有助于对CR1进行进一步表征。